Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV -1 Infection”

Showing 20 of 0 results

Not applicableLooking for participantsNCT06834113
What this trial is testing

Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventrogluteal or Dorsogluteal) and the Use or Non-use of Virtual Reality Headset

Who this might be right for
HIV I InfectionInjection Pain
Centre Hospitalier Régional d'Orléans 120
Large-scale testing (Phase 3)Study completedNCT01309243
What this trial is testing

Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

Who this might be right for
HIV-1 Infection
Gilead Sciences 799
Not applicableWithdrawnNCT00000835
What this trial is testing

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of an HIV-1 Pseudovirion Vaccine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Active Not RecruitingNCT05527418
What this trial is testing

Safety, Tolerance and Antiretroviral Activity of Dasatinib: a Pilot Clinical Trial in Patients With Recent HIV-1 Infection

Who this might be right for
Recent HIV-1 Infection
Eva Bonfill 24
Early research (Phase 1)Study completedNCT00011479
What this trial is testing

Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Testing effectiveness (Phase 2)WithdrawnNCT03549689
What this trial is testing

Effect of Reducing Nucleotide Exposure on Bone Health (ReNew)

Who this might be right for
HIV/AIDSHIV-1-infectionOsteopenia
Philip Grant
Not applicableStudy completedNCT02592174
What this trial is testing

Prevalence, Characteristics and Risk Factors of HIV-Associated Neurocognitive Disorders in Subjects Between the Ages of 55 and 70 Years: An Exposed/Unexposed Cross Sectional Study

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 220
Testing effectiveness (Phase 2)Ended earlyNCT00513513
What this trial is testing

TMC114-C227: A Study to Evaluate the Effectiveness and Safety of TMC114 (Darunavir) With a Low Dose of Ritonavir as Monotherapy (no Other Anti-HIV Drugs Will be Given) in Patients Who Have Never Been Treated With Antiretrovirals (Anti-HIV Drugs) Previously

Who this might be right for
HIV Infections
Tibotec Pharmaceuticals, Ireland 7
Early research (Phase 1)Looking for participantsNCT07525544
What this trial is testing

Investigate the Safety and PK of VH4770359 in Healthy Participants

Who this might be right for
HIV Infections
ViiV Healthcare 214
Large-scale testing (Phase 3)Study completedNCT00323544
What this trial is testing

SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection

Who this might be right for
HIV Infections
Gilead Sciences 220
Large-scale testing (Phase 3)UnknownNCT01316744
What this trial is testing

Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain

Who this might be right for
Cancer
University of Glasgow 214
Not applicableStudy completedNCT00672932
What this trial is testing

Raltegravir Augmentation on Persistent Central Nervous System (CNS) Immunoactivation in Treated HIV-1 Patients

Who this might be right for
HIV Infections
University of California, San Francisco 18
Large-scale testing (Phase 3)Active Not RecruitingNCT04776252
What this trial is testing

Open-label, Follow-up of Doravirine/Islatravir (DOR/ISL 100 mg/0.75mg) for Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection (MK-8591A-033)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 2,000
Early research (Phase 1)Study completedNCT00001647
What this trial is testing

White Blood Cell Infusions to Treat HIV Infection

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 30
Large-scale testing (Phase 3)UnknownNCT05154747
What this trial is testing

Long-Acting Treatment in Adolescents (LATA)

Who this might be right for
HivHIV InfectionsHIV-1-infection+1 more
University College, London 476
Early research (Phase 1)Study completedNCT00099671
What this trial is testing

Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 25
Large-scale testing (Phase 3)Active Not RecruitingNCT05631093
What this trial is testing

A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Antiretroviral Therapy (ART) (MK-8591A-051)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 553
Not applicableStudy completedNCT00373048
What this trial is testing

Mefloquine Prophylaxis in HIV-1 Individuals: a Randomized Placebo-controlled Trial

Who this might be right for
HIV Infections
Institute of Tropical Medicine, Belgium 300
Not applicableLooking for participantsNCT05973825
What this trial is testing

Immuno-virological Evaluation of Persons Living With HIV (PLWH)

Who this might be right for
HIV-1-infectionHIV Seropositivity
University Hospital, Ghent 24
Large-scale testing (Phase 3)Study completedNCT00144287
What this trial is testing

Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment Options

Who this might be right for
HIV Infections
Boehringer Ingelheim 255
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation